- University of Southern California (J.D., 2006); Order of the Coif; Executive Articles Editor of the Southern California Law Review
- Washington University, St. Louis (B.A., History, 1994), with Honors
Josh Gordon is counsel in the Los Angeles office of Irell & Manella LLP, where he is a member of the firm's litigation practice group. Mr. Gordon has represented both individuals and corporations in a variety of intellectual property and other commercial disputes. His practice spans various industries, having represented clients in the entertainment, technology, life-sciences, telecommunications, and consumer-electronics industries. He has experience in both state and federal court, as well as in mediations, arbitrations and before a federal administrative commission. Mr. Gordon and his colleagues have secured key rulings on motion practice and appellate review, arbitration victories, multi-million dollar settlements, and the release of all claims against their clients prior to and after trial.
In addition to his practice, Mr. Gordon is actively involved in the firm's Hiring and Mentoring Committees and is currently the co-chair of the firm’s Summer Committee. He is a member of the Los Angeles Dodgers Foundation RBI Advisory Committee. Super Lawyers magazine named Mr. Gordon to the Southern California Super Lawyers list in 2017 and 2018 after naming him to the Southern California Rising Stars list from 2014-2016.
Mr. Gordon earned his J.D. from the University of Southern California, where he was the executive articles editor of the Southern California Law Review. He authored "Pacifica is Dead. Long Live Pacifica: Formulating a New Argument Structure to Preserve Government Regulation of Indecent Broadcasts," 79 S. Cal. L. Rev. 1451 (2006). Mr. Gordon had the honor of serving as a judicial extern to the Honorable Candace Cooper of the California Court of Appeal for the Second District.
Prior to law school, Mr. Gordon held management positions in entrepreneurial ventures in the professional sports and e-commerce industries.
- Ariosa Diagnostics, Inc. v. Sequenom, Inc.
Represented Ariosa Diagnostics in well-publicized proceedings in which a Federal Circuit panel affirmed the District Court’s summary judgment order invalidating Sequenom’s patent for failing to claim patent-eligible subject matter. The Federal Circuit subsequently declined to rehear that decision en banc and the United States Supreme Court denied Sequenom’s petition for review.
- PDL BioPharma v. Merck
Represented PDL BioPharma in patent litigation against Merck alleging that Merck’s manufacture of its cancer drug Keytruda infringed a foundational patent relating to the humanization of recombinant antibodies. The case settled little more than one year after it was filed, following the claim construction hearing, with Merck making a $19.5-million lump-sum payment to PDL.
- QED Holdings, LLC v. QED International, LLC and William H. Block, et al.
Represented QED Holdings, LLC, an independent film company, in trademark, contract and tort proceedings, both in federal court and arbitration. The proceedings resolved to the satisfaction of all parties.
- Currently representing one of Hollywood's largest studios in a well-publicized class action alleging that the studios have failed to account properly for the exploitation of motion pictures on home video.
- Verinata Health, Inc. and Illumina, Inc. v. Ariosa Diagnostics
Represented Ariosa Diagnostics in three consolidated patent infringement suits in the Northern District of California which, like the action involving Sequenom, sought to enjoin Ariosa from selling its innovative non-invasive test for fetal chromosomal abnormalities. Ariosa persuaded the district court to stay the cases, which involve three patents, pending inter partes reviews and appeals to the Federal Circuit.
- PDL BioPharma, Inc. v. Genentech, Inc. and F. Hoffmann-La Roche Ltd.
Represented PDL BioPharma in a Nevada state court action alleging breach of a 2003 settlement agreement that, among other things, barred Genentech from taking any action to challenge the validity of certain PDL patent rights. After extensive discovery and motion practice, the case was stayed by agreement of the parties pending Genentech and Roche’s interlocutory appeal to the Nevada Supreme Court of a trial court order granting PDL’s motion to compel them to produce critical documents withheld on grounds of privilege. The case settled during the appeal, with Genentech entering into amended license agreements with PDL. Certain details about the settlement can be found in PDL’s public disclosures.
- Represented TiVo Inc. against Microsoft, Verizon, and Samsung, including before the International Trade Commission. The cases resolved favorably to TiVo, including a settlement in which Verizon agreed to provide TiVo with total compensation worth at least $250.4 million.
- Successfully prosecuted, on behalf of Walt Disney Pictures, a trademark infringement action concerning Disney's rights in the motion picture, "Frozen."
- Represented the Natural Resources Defense Council in highly publicized litigation involving the effects of naval sonar on marine mammals. Mr. Gordon participated in the litigation before a federal district court, the 9th Circuit Court of Appeals, and the United States Supreme Court.
- Successfully represented several major motion picture studios in contract disputes.
- Won a complete victory in an arbitration proceeding, preserving his client's 100% rights to a highly-successful video game franchise.
- Represented a major telecommunications company in negotiations and a subsequent arbitration, obtaining a settlement of over $50 million and additional relief.
- Obtained positive settlements for multiple technology companies in licensing and patent disputes.
- California, 2006
- U.S. District Court, Central and Northern Districts of California
- U.S. Court of Appeals, Ninth Circuit and Federal Circuit